Overview

Pilot Study of Presurgical Tremelimumab With or Without Cryoablation in Patients With Metastatic Renal Cell Carcinoma (RCC)

Status:
Recruiting

Trial end date:
0000-00-00

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to compare the safety and effectiveness of tremelimumab alone and in combination with cryoablation in patients with metastatic kidney cancer having surgery. Researchers also want to learn how the combination may affect the immune system. Cryoablation is a procedure that uses a hollow, thin tube called a cryoprobe to freeze and destroy cancer tissue.

Phase:

N/A

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborator:

MedImmune LLC

Treatments:

Antibodies, Monoclonal
Tremelimumab